Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
101	101 Cytokinetics CYTK $4.13B	122% upside 11 price targets	0
102	102 Immunovant IMVT $2.86B	120% upside 3 price targets	0
103	103 Innoviz Technologies INVZ $219M	119% upside 3 price targets	0
104	104 Eton Pharmaceutcials ETON $421M	118% upside 3 price targets	0
105	105 Avidity Biosciences RNA $4.05B	118% upside 8 price targets	0
106	PVLA 106 Palvella Therapeutics, Inc. Common Stock PVLA $290M	117% upside 5 price targets	0
107	107 Amylyx Pharmaceuticals AMLX $513M	116% upside 4 price targets	0
108	108 Arcus Biosciences RCUS $1.06B	116% upside 4 price targets	0
109	109 CG Oncology CGON $2.09B	115% upside 6 price targets	0
110	110 Viasat VSAT $1.72B	113% upside 3 price targets	0
111	111 Forge Global Holdings FRGE $194M	112% upside 3 price targets	0
112	112 KalVista Pharmaceuticals KALV $706M	111% upside 3 price targets	0
113	113 Denali Therapeutics DNLI $2.22B	111% upside 4 price targets	0
114	114 Immunocore IMCR $1.8B	110% upside 5 price targets	0
115	115 Stagwell STGW $1.28B	109% upside 4 price targets	0
116	116 Quanterix QTRX $255M	106% upside 3 price targets	0
117	117 Legend Biotech LEGN $6.93B	105% upside 4 price targets	0
118	118 Liquidia Corp LQDA $1.28B	104% upside 7 price targets	0
119	119 Akebia Therapeutics AKBA $919M	104% upside 4 price targets	0
120	120 Sutro Biopharma STRO $70.9M	103% upside 3 price targets	0
121	121 Iris Energy IREN $2.36B	102% upside 4 price targets	0
122	122 Castle Biosciences CSTL $521M	101% upside 3 price targets	0
123	123 Corcept Therapeutics CORT $7.66B	98% upside 4 price targets	0
124	124 Enovis ENOV $1.92B	96% upside 3 price targets	0
125	125 Cogent Biosciences COGT $845M	92% upside 3 price targets	0

1

34567

65